Pacylex

Pacylex Pharmaceuticals Presents New Data on the Mechanism of Action of Myristoylation Inhibition

A myristoylation inhibition gene expression signature, MISS-91 (Myristoylation Inhibitors Sensitivity Signature), will be presented at the European Association for Cancer Research (EACR) 2023 Congress.

Read More

Recent News

Pacylex

Pacylex Pharmaceuticals Selected as One of Sixteen Canadian Startup Companies to Present at Sweet Biopharma Day 2023

Read More

Pacylex

Pacylex Pharmaceuticals Announces New Executive Team Members as the Company Accelerates Clinical Development of PCLX-001

Read More

Pacylex

Pacylex Pharmaceuticals to Present at Biotech Showcase™ 2023

Read More
Follow Pacylex